Finasteride Tablet, Film Coated
Product Images NDC 71335-0433

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Finasteride (NDC 71335-0433). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Finasteride Fig 1)

Chemical structure diagram of finasteride, showing its steroid-like fused ring system with attached functional groups including a ketone and an amide moiety.*

FDA Label Image

Image Of Figure 1 (Finasteride Fig 2)

A line graph showing mean change from baseline with standard error for Finasteride and Placebo over four years. The vertical axis represents mean change while the horizontal axis shows time from baseline to Year 4. Two lines plot data points for Finasteride and Placebo, with Finasteride showing a greater reduction over time compared to Placebo. Sample sizes are noted below the baseline and yearly markers.*

FDA Label Image

Image Of Figure 2 (Finasteride Fig 3)

A line graph depicting the percent of patients over observation time in months for two groups: Finasteride and Placebo. The graph shows the cumulative percent increasing over time with the Finasteride group consistently higher than the Placebo group. Below the graph, a table presents the number of events and number at risk per year for both groups.*

FDA Label Image

Image Of Figure 3 (Finasteride Fig 4)

A line chart depicting mean percent change from baseline plus one standard error (SE) over four years. The chart compares two groups labeled Placebo and Finasteride, showing diverging trends after baseline, with sample sizes noted at each time point for both groups.*

FDA Label Image

Image Of Figure 4 (Finasteride Fig 5)

A line graph showing the percentage of participants with an event over time in years from randomization, comparing four groups: Placebo, Finasteride, Doxazosin, and Combination. The vertical axis indicates the percent with event, and the horizontal axis shows years from 0 to 5.5. The graph illustrates that placebo group has the highest percentage of events, followed by finasteride, doxazosin, and the combination group with the lowest percentage.*

FDA Label Image

Label Image (Lbl713350433)

Finasteride 5 mg film-coated tablet packaging label showing the product name and strength prominently. The label references comparison to Proscar 5 mg tablet by Intas Pharmaceuticals Limited. It indicates a quantity of 100 tablets and storage instructions at room temperature 20-25°C (68-77°F). The labeler is Bryant Ranch Prepack, located in Burbank, CA, and includes barcodes and an NDC number 71335-0433.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.